IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors	Unresectable Locally Advanced or Metastatic Solid Tumors	Recruiting	Phase 1 / Phase 2	2026-01-29		NCT06974812

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Innovent Biologics (Suzhou) Co. Ltd.	82

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Fujian Cancer Hospital	Fuzhou	China	109
Hunan Cancer Hospital	Changsha	China	41
Shanghai Pulmonary Hospital	Shanghai	China	72

Clinical trials